Most medical supply buyers negotiate the wrong number. We compare unit prices, sign the purchase order, and then treat the supplier's 'estimated delivery' as if it were a firm date. I've been managing procurement for a multi-site clinic since 2020, and here's the blunt truth: price is the number we quote, but delivery certainty is the number we're actually buying.
I say this as an office administrator, not a clinician. I process something like 60-80 purchase orders a year across nine vendors—maybe $500,000 in medical and non-medical supplies annually. I report to operations and finance. My job isn't to know every clinical detail. It's to make sure the right product is in the right place before the clinician needs it. And that makes me a supply chain person first and a shopper second.
What I learned from a $400 rush charge
One of my clearest moments came in March 2024. A home-care discharge needed a portable oxygen concentrator, and our usual vendor let us down twice (surprise, surprise). We paid an extra $400 to get one delivered in two days instead of seven. Some people would call that wasted money. I call it buying a guarantee that a patient's discharge didn't get pushed, and that the operations director didn't have to make a difficult phone call.
People think rush delivery costs more because it's faster. Actually, it costs more because it replaces a probability with a certainty. When a supplier says 'usually 5-7 business days,' they haven't given me a commitment. They've given me a hope. If that hope falls through during a clinical need, the low price is meaningless.
A part number is not a product
Last week, a nurse submitted an order for a Smiths Medical 21-7322-24. I'm not going to pretend I can recite its exact dimensions from memory. I know it's the kind of airway product that has to match the patient's anatomy, and I know that a close-looking substitute is not good enough. My job is to double-check the code, confirm the size, and make sure it's in the contract catalog.
In 2021, I ordered what looked like an equivalent tracheostomy tube from a lower-cost brand. The spec sheet looked almost identical. It wasn't. The airway team noticed a dimensional difference before use, and we had to discard the entire lot and go back to the original Smiths Medical product. That box was expensive. The loss of clinical trust was worse.
With medical supplies, a part number is not a product until it's verified. A 15% saving on something the clinicians can't use has negative value, not reduced cost.
What is infection control? It's a purchasing problem.
I used to think infection control meant hand sanitizer, masks, and wall posters. Then I realized how much of it depends on supply decisions. Infection control is the term healthcare uses for everything a facility does to prevent pathogens from moving between patients, staff, and visitors. Hand hygiene, PPE, sterilization, cleaning, and the medical devices that touch patients all play a role.
As of early 2025, CDC's standard precautions—the framework formalized in the 2007 Guideline for Isolation Precautions—remain the backbone of U.S. infection prevention. The idea is simple: treat every patient as potentially infectious. That makes product selection part of the protocol. Closed IV systems, needle-free connectors, safety engineered catheters, single-use airway devices: these are not accessories. They're the infrastructure of infection control.
That's why I don't treat Smiths Medical products like ordinary line items. Jelco IV catheters, Portex airway devices, and infusion systems are bought for what they prevent as much as what they do. A device that reduces one line infection pays for a lot of boxes. An infection control failure can cost thousands of dollars in treatment—and worse, it costs patient trust.
Of course, infection control is not only about choosing premium products. Training, audits, and basic hand hygiene still matter. But a buyer who ignores the infection-control consequences of a cheap alternative is saving pennies to subsidize dollars of risk.
The same logic applies in the veterinary world. When we added a small-animal referral service in 2024, we stocked Smiths Medical veterinary airway and anesthesia supplies. A three-pound emergency patient doesn't care about quarterly savings targets. If the right tube isn't there, you improvise—and improvisation has no place in infection control.
A chemistry analyzer taught me the same lesson
My order queue in a typical month might include a portable oxygen concentrator, a chemistry analyzer for the lab, and a case of Smiths Medical 21-7322-24. Very different items, same decision framework.
When we bought the chemistry analyzer, we didn't choose the lowest bid. We chose the vendor that would commit to an installation date because the entire lab schedule depends on it. For the portable oxygen concentrator, the delivery date was itself a clinical intervention. And for Smiths Medical consumables, the 'installation date' is simply before the current box runs out.
Here's the metric I wish more administrators tracked: how often does an 'estimated' delivery turn into an expedited order? When I compared our Q3 and Q4 expedite fees side by side—same vendors, different ordering timing—I finally understood why the cheaper supplier was the most expensive one.
But isn't certainty just a reason to pay more?
Maybe. I'm not saying every rush fee or guaranteed delivery premium is worth it. If a vendor charges 30% extra but their late-delivery record is no better than anyone else's, you've bought a label, not a guarantee. Ask for the commitment in writing. Ask what happens if they miss it. If they won't stand behind the date, the certainty isn't real.
This approach also works because our clinic has predictable usage and enough storage. If you're a small practice with irregular ordering patterns or no room for backup stock, your cost-benefit calculation will look different. I can only speak to what I've seen in my setting.
Bottom line: in medical supply purchasing, the cheapest bid is rarely the cheapest strategy. The question isn't 'is this product a good price?' It's 'will it be here, correct, and ready when the patient is?' If I'm confident, I'll pay a little more. If I'm not, no discount is big enough.
